Table 3.
Cases per 100 000 |
||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
Total |
Male |
Female |
||||||||||
Model 1 | Model 2 | Model 3 | Model 1 | Model 2 | Model 3 | Model 1 | Model 2 | Model 3 | ||||
Treatment effect | 4.785 (0.997)** | 1.660 (1.451) | 1.857 (1.212) | 3.739 (0.676)** | 0.767 (1.008) | 0.945 (0.904) | 1.046 (0.342)** | 0.893 (0.484)† | 0.911(0.392)* | |||
Time trends1 | ||||||||||||
2008 | -1.168 (0.580)† | -1.267 (0.665)† | -0.776 (0.354)* | -0.777 (0.451) | -0.392 (0.276) | -0.490 (0.302) | ||||||
2009 | -0.968 (0.819) | -3.762 (1.531)* | -0.582 (0.531) | -3.205 (1.230)* | -0.386 (0.395) | -0.556 (0.646) | ||||||
2010 | -1.235 (1.170) | -3.553 (2.246) | -0.467 (0.865) | -2.805 (1.736) | -0.769 (0.374)† | -0.748 (0.782) | ||||||
2011 | -0.652 (1.401) | -2.013 (2.286) | -0.232 (1.040) | -1.718 (1.719) | -0.420 (0.432) | -0.296 (0.689) | ||||||
2012 | 1.563 (1.450) | -0.831 (2.718) | 1.825 (1.108) | -0.606 (1.965) | -0.261 (0.423) | -0.225 (0.813) | ||||||
2013 | 2.892 (1.541)† | 1.299 (3.171) | 2.911 (1.191)* | 1.139 (2.473) | -0.018 (0.435) | 0.160 (0.808) | ||||||
2014 | 4.825 (1.774)* | 3.887 (3.692) | 4.341 (1.290)** | 3.063 (2.671) | 0.484 (0.529) | 0.824 (1.134) | ||||||
2015 | 3.842 (1.400)* | 4.423 (3.581) | 3.931 (0.964)** | 3.887 (2.633) | -0.089 (0.461) | 0.536 (1.227) | ||||||
2016 | 4.942 (1.334)** | 4.662 (3.625) | 4.902 (0.992)** | 4.161 (2.713) | 0.040 (0.466) | 0.501 (1.204) | ||||||
Covariates | ||||||||||||
No. of medical facilities | ||||||||||||
Tertiary hospital | 0.721 (0.497) | 0.575 (0.386) | 0.146 (0.132) | |||||||||
Secondary hospital | 0.055 (0.258) | -0.042 (0.170) | 0.097 (0.114) | |||||||||
Clinic | -0.004 (0.011) | -0.002 (0.007) | -0.002 (0.004) | |||||||||
No. of medical personnel | ||||||||||||
Internal medicine | 0.003 (0.012) | 0.001 (0.008) | 0.001 (0.003) | |||||||||
Emergency medicine | 0.020 (0.084) | 0.011 (0.061) | 0.009 (0.025) | |||||||||
General practitioners | -0.001 (0.002) | -0.000 (0.001) | -0.000 (0.000) | |||||||||
Population aged >65 (%) | 0.073 (0.527) | 0.063 (0.376) | 0.009 (0.195) | |||||||||
GRDP per capita (million Korean won) | -0.188 (0.104)† | -0.085 (0.076) | -0.103 (0.032)** | |||||||||
Health-related behavior (%) | ||||||||||||
High-risk alcohol consumption | -0.279 (0.183) | -0.268 (0.166) | -0.011 (0.080) | |||||||||
Prevalence of hypertension | 0.536 (0.583) | 0.458 (0.424) | 0.078 (0.184) | |||||||||
Control rate of hypertension | -0.059 (0.179) | -0.093 (0.148) | 0.034 (0.071) | |||||||||
Prevalence of diabetes | -0.230 (0.631) | -0.116 (0.460) | -0.114 (0.228) | |||||||||
Control rate of diabetes | 0.216 (0.094)* | 0.203 (0.080)* | 0.013 (0.022) | |||||||||
Prevalence of perceived obesity | -0.055 (0.153) | -0.029 (0.122) | -0.026 (0.056) | |||||||||
Prevalence of perceived stress | -0.062 (0.130) | -0.068 (0.113) | 0.006 (0.044) | |||||||||
Prevalence of smoking | 1.024 (0.362)* | 0.849 (0.272)** | 0.175 (0.192) | |||||||||
Constant | 26.540 (0.512)** | 26.740 (0.662)** | -4.454 (28.380) | 18.770 (0.347)** | 18.71 (0.451)** | -6.842 (20.100) | 7.768 (0.176)** | 8.028 (0.245)** | 2.388 (11.250) | |||
Within R2 | 0.246 | 0.592 | 0.689 | 0.234 | 0.646 | 0.733 | 0.143 | 0.240 | 0.360 |
Robust standard errors in parentheses.
RCCVC, Regional Cardiocerebrovascular Center; GRDP, gross regional domestic product.
Year 2007 as reference.
p<0.1,
p<0.05,
p<0.01.